Pauline Vaflard

Comparative Analysis of Durable Responses on Immune Checkpoint Inhibitors Versus Other Systemic Therapies: A Pooled Analysis of Phase III Trials

Elvire Pons‐Tostivint, Aurélien Latouche, Pauline Vaflard et al. · JCO Precision Oncology · 2019 · 100 citations

Medicine, Immunology, Oncology +16

Relevance of a molecular tumour board (MTB) for patients’ enrolment in clinical trials: experience of the Institut Curie

Clémence Basse, Claire Morel, Marie Alt et al. · ESMO Open · 2018 · 55 citations · Full text

Medicine, Oncology, Pathology +17

Prospective Evaluation of Ultrafast Breast MRI for Predicting Pathologic Response after Neoadjuvant Therapies

Toulsie Ramtohul, Clara Tescher, Pauline Vaflard et al. · Radiology · 2022 · 44 citations

Medicine, Oncology, Radiology +17

Avelumab vs Standard Second-Line Chemotherapy in Patients With Metastatic Colorectal Cancer and Microsatellite Instability

Olivier Bouché, Thierry André, Karine Le Malicot et al. · JAMA Oncology · 2023 · 43 citations · Full text

Medicine, Oncology, Pharmacology +17

Sacituzumab govitecan in metastatic triple-negative breast cancer patients treated at Institut Curie Hospitals: efficacy, safety, and impact of brain metastases

Alexandre De Moura, Delphine Loirat, Sinen Korbi et al. · Breast Cancer · 2024 · 32 citations · Full text

Medicine, Oncology, Pharmacotherapy +17